SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-007656
Filing Date
2023-01-30
Accepted
2023-01-30 06:02:08
Documents
21
Period of Report
2023-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm234839d1_8k.htm   iXBRL 8-K 26015
2 EXHIBIT 99.1 tm234839d1_ex99-1.htm EX-99.1 214375
3 EXHIBIT 99.2 tm234839d1_ex99-2.htm EX-99.2 214996
7 GRAPHIC tm234839d1_ex99-1img001.jpg GRAPHIC 16499
8 GRAPHIC tm234839d1_ex99-1img002.jpg GRAPHIC 11296
9 GRAPHIC tm234839d1_ex99-1img003.jpg GRAPHIC 4862
10 GRAPHIC tm234839d1_ex99-1img004.jpg GRAPHIC 12549
11 GRAPHIC tm234839d1_ex99-2img001.jpg GRAPHIC 3987
12 GRAPHIC tm234839d1_ex99-2img002.jpg GRAPHIC 3156
13 GRAPHIC tm234839d1_ex99-2img003.jpg GRAPHIC 6722
  Complete submission text file 0001104659-23-007656.txt   776694

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srne-20230129.xsd EX-101.SCH 3069
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20230129_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20230129_pre.xml EX-101.PRE 22619
15 EXTRACTED XBRL INSTANCE DOCUMENT tm234839d1_8k_htm.xml XML 3486
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 23565087
SIC: 2836 Biological Products, (No Diagnostic Substances)